A new family of quinoline and quinoxaline analogues of combretastatins

Bioorg Med Chem Lett. 2004 Jul 16;14(14):3771-4. doi: 10.1016/j.bmcl.2004.04.098.

Abstract

The 3-hydroxy-4-methoxyphenyl ring of combretastatin A-4 can be replaced by a 2-naphthyl moiety without significant loss of cytotoxicity and inhibition of tubulin polymerization potency. In this paper we show that the 6- or 7-quinolyl systems can in turn replace both cyclic moieties, keeping in the first case most of the potency as cytotoxic agent and in the second case as inhibitor of tubulin polymerization, related to the activities displayed by model compounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Biopolymers / chemistry
  • Cell Line, Tumor
  • Humans
  • Inhibitory Concentration 50
  • Ligands
  • Naphthalenes / chemistry
  • Quinolines / chemistry*
  • Quinoxalines / chemistry*
  • Stilbenes / chemical synthesis*
  • Stilbenes / pharmacology
  • Structure-Activity Relationship
  • Tubulin / chemistry
  • Tubulin Modulators*

Substances

  • Antineoplastic Agents
  • Biopolymers
  • Ligands
  • Naphthalenes
  • Quinolines
  • Quinoxalines
  • Stilbenes
  • Tubulin
  • Tubulin Modulators
  • quinoline
  • fosbretabulin